Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PZ-128 in non-emergent percutaneous coronary intervention (TRIP-PCI)
NCT02561000Phase 2Completed
- Sponsor
- Tufts Medical Center
- Start
- May 2016
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PZ-128 in coronary artery disease (CAD), sponsored by Tufts Medical Center. Started May 2016; status: completed.
02
Drugs
PZ-128
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02561000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561000.